Understanding how all of these variables interact and impact the p53-regulated response to DNA damage in primary and tumor cells will be important both for developing strategies for prevention of cancer in healthy individuals and for understanding outcomes in cytotoxic therapy for cancer. The gene discussed is TP53; the disease is neoplasm.